FP069ROLE OF SOLUBLE FORM AND EXTRACELLULAR VESICLE (EV)-CARRIED CD40LIGAND (CD40L) AS BIOMARKER OF DISEASE ACTIVITY AND AS MEDIATOR OF MICROVASCULAR ENDOTHELIAL INJURY IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY (AKI) AND IN END STAGE RENAL DISEASE (ESRD) PATIENTS